CG
KURA icon

Cutler Group’s Kura Oncology KURA Stock Holding History

Cutler Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-280
Closed -$8.86K – 5980
2020
Q4 		$9K Sell
280
-1,120
-80% -$39.4K ﹤0.01% 3273
2020
Q3 		$42K Buy
+1,400
New +$30.9K ﹤0.01% 1904
2020
Q2 		– Sell
-600
Closed -$5K – 4643
2020
Q1 		$5K Hold
600
– – ﹤0.01% 3088
2019
Q4 		$8K Buy
+600
New +$8.89K ﹤0.01% 2761

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cutler Group's KURA Position: Q1 2021 in Review

Cutler Group sold out of Kura Oncology (KURA) in Q1 2021, closing a stake of 280 shares — an estimated $8.86K sold.

Cutler Group first reported a position in KURA in Q4 2019 and held it in 4 quarters. The position peaked at $42K in Q3 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

  • Cutler Group reported no remaining Kura Oncology position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 280 Kura Oncology shares in Q1 2021, an estimated $8.86K.
  • Cutler Group first reported a position in Kura Oncology in Q4 2019 and held it in 4 quarters.
  • Cutler Group's Kura Oncology position peaked at $42K in Q3 2020.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.